By Jan. 1, 2019, all Indiana healthcare providers who hold a controlled substance registration (CSR) must register with INSPECT, the state’s prescription drug monitoring program, and practitioners in hospital emergency departments and pain management clinics must begin querying INSPECT when prescribing opioids or benzodiazepines based on legislation passed during the 2018 General Assembly.
Namely, Senate Bill 221 expanded the electronic methods by which dispensers of opioids or benzodiazepines can transmit information to INSPECT and also created a phased schedule for requiring all healthcare practitioners to obtain information about patients from the database before prescribing opioids or benzodiazepines. As mentioned above, providers in emergency departments and pain clinics must begin querying INSPECT as of January 1, 2019. All other practitioners who provide services in hospitals must begin querying INSPECT by January 1, 2020, and all remaining Indiana providers must come on board by January 1, 2021.
The requirement for all providers holding a CSR in Indiana to be registered with INSPECT by January 1, 2019, is not specific to practice setting, however. According to the Indiana State Medical Association (ISMA), failure to do so, as well as failure to perform the INSPECT queries according to the required schedule, will constitute a Class A misdemeanor.
Registering with INSPECT is free and can be done online. You will need the following information in order to register: an individual email address only you, the physician, can access; your CSR number; your DEA number; your medical license number; and your driver’s license number.
To make the querying process faster and easier, INSPECT may also be integrated with existing EHR systems. For more information, review the INSPECT Integration Initiative – Integration Request Form.
— All rights reserved. For use or reprint in your blog, website, or publication, please contact us at cipromsmarketing@ciproms.com.
